0000000000607782

AUTHOR

Silvana Maisano

showing 4 related works from this author

Calprotectin in the prediction of endoscopic post-surgical recurrence in CD

2005

researchProduct

CA-19 to rule out Pancreatic or Biliary Cancer among patients with cholestasis:an unsuitable ?

2007

Biliary Cancer
researchProduct

The Role of Gemtuzumab Ozogamicin in Elderly AML Patients in Complete Remission.

2007

Abstract The majority of patients (pts) with acute myeloid leukemia (AML) are diagnosed in their 6th and 7th decade of life. AML in elderly pts is associated with poor response to conventional chemotherapy and limited long-term survival, reflecting a higher incidence multidrug resistance mechanisms, a low bone marrow reserve which may prevent/delay the recovery of hematopoiesis after treatment, and the occurrence of co-morbidities. Gemtuzumab ozogamicin (GO) is an immunoconjugate with a humanized anti-CD33 that after internalization, releases a cytotoxic drug, calicheamicin; ≥80% of AML pts have myeloid blast cells that express the CD33 surface antigen. GO as a single agent has low antileuk…

Oncologymedicine.medical_specialtyGemtuzumab ozogamicinbusiness.industryImmunologyCombination chemotherapyCell BiologyHematologyHematology myeloid leukemia (AML)BiochemistrySurgeryFludarabineMaintenance therapyInternal medicineCyclosporin amedicineFLAG (chemotherapy)IdarubicinbusinessEtoposidemedicine.drugBlood
researchProduct

NOD2/CARD15 FREQUENCY IN CROHN'DISEASE IN SICILY:AN EPIDEMIOLOGICAL STUDY

2005

researchProduct